Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy: design of the DAHANCA 31 randomized trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy : design of the DAHANCA 31 randomized trial. / Lonkvist, Camilla K; Lønbro, Simon; Vinther, Anders; Zerahn, Bo; Rosenbom, Eva; Primdahl, Hanne; Hojman, Pernille; Gehl, Julie.

In: B M C Cancer, Vol. 17, 400, 03.06.2017.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lonkvist, CK, Lønbro, S, Vinther, A, Zerahn, B, Rosenbom, E, Primdahl, H, Hojman, P & Gehl, J 2017, 'Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy: design of the DAHANCA 31 randomized trial', B M C Cancer, vol. 17, 400. https://doi.org/10.1186/s12885-017-3388-0

APA

Lonkvist, C. K., Lønbro, S., Vinther, A., Zerahn, B., Rosenbom, E., Primdahl, H., ... Gehl, J. (2017). Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy: design of the DAHANCA 31 randomized trial. B M C Cancer, 17, [400]. https://doi.org/10.1186/s12885-017-3388-0

Vancouver

Lonkvist CK, Lønbro S, Vinther A, Zerahn B, Rosenbom E, Primdahl H et al. Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy: design of the DAHANCA 31 randomized trial. B M C Cancer. 2017 Jun 3;17. 400. https://doi.org/10.1186/s12885-017-3388-0

Author

Lonkvist, Camilla K ; Lønbro, Simon ; Vinther, Anders ; Zerahn, Bo ; Rosenbom, Eva ; Primdahl, Hanne ; Hojman, Pernille ; Gehl, Julie. / Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy : design of the DAHANCA 31 randomized trial. In: B M C Cancer. 2017 ; Vol. 17.

Bibtex

@article{833f385683104fbb9e15090638a88fb5,
title = "Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy: design of the DAHANCA 31 randomized trial",
abstract = "BACKGROUND: Head and neck cancer patients undergoing concomitant chemoradiotherapy (CCRT) frequently experience loss of muscle mass and reduced functional performance. Positive effects of exercise training are reported for many cancer types but biological mechanisms need further elucidation. This randomized study investigates whether progressive resistance training (PRT) may attenuate loss of muscle mass and functional performance. Furthermore, biochemical markers and muscle biopsies will be investigated trying to link biological mechanisms to training effects.METHODS: At the Departments of Oncology at Herlev and Aarhus University Hospitals, patients with stage III/IV squamous cell carcinoma of the head and neck, scheduled for CCRT are randomized 1:1 to either a 12-week PRT program or control group, both with 1 year follow-up. Planned enrollment is 72 patients, and stratification variables are study site, sex, p16-status, and body mass index. Primary endpoint is difference in change in lean body mass (LBM) after 12 weeks of PRT, assessed by dual-energy X-ray absorptiometry (DXA). The hypothesis is that 12 weeks of PRT can attenuate the loss of LBM by at least 25{\%}. Secondary endpoints include training adherence, changes in body composition, muscle strength, functional performance, weight, adverse events, dietary intake, self-reported physical activity, quality of life, labor market affiliation, blood biochemistry, plasma cytokine concentrations, NK-cell frequency in blood, sarcomeric protein content in muscles, as well as muscle fiber type and fiber size in muscle biopsies. Muscle biopsies are optional.DISCUSSION: This randomized study investigates the impact of a 12-week progressive resistance training program on lean body mass and several other physiological endpoints, as well as impact on adverse events and quality of life. Furthermore, a translational approach is integrated with extensive biological sampling and exploration into cytokines and mechanisms involved. The current paper discusses decisions and methods behind exercise in head and neck cancer patients undergoing concomitant chemoradiotherapy.TRIAL REGISTRATION: Approved by the Regional Ethics Committee for the Capital Region of Denmark (protocol id: H-15003725) and registered retrospectively at ClinicalTrials.gov ( NCT02557529 ) September 11th 2015.",
keywords = "Aged, Body Composition/physiology, Body Mass Index, Carcinoma, Squamous Cell/diagnostic imaging, Chemoradiotherapy/adverse effects, Denmark, Exercise, Female, Head and Neck Neoplasms/diagnostic imaging, Humans, Male, Middle Aged, Muscle Strength/drug effects, Quality of Life, Resistance Training",
author = "Lonkvist, {Camilla K} and Simon L{\o}nbro and Anders Vinther and Bo Zerahn and Eva Rosenbom and Hanne Primdahl and Pernille Hojman and Julie Gehl",
year = "2017",
month = "6",
day = "3",
doi = "10.1186/s12885-017-3388-0",
language = "English",
volume = "17",
journal = "B M C Cancer",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy

T2 - design of the DAHANCA 31 randomized trial

AU - Lonkvist, Camilla K

AU - Lønbro, Simon

AU - Vinther, Anders

AU - Zerahn, Bo

AU - Rosenbom, Eva

AU - Primdahl, Hanne

AU - Hojman, Pernille

AU - Gehl, Julie

PY - 2017/6/3

Y1 - 2017/6/3

N2 - BACKGROUND: Head and neck cancer patients undergoing concomitant chemoradiotherapy (CCRT) frequently experience loss of muscle mass and reduced functional performance. Positive effects of exercise training are reported for many cancer types but biological mechanisms need further elucidation. This randomized study investigates whether progressive resistance training (PRT) may attenuate loss of muscle mass and functional performance. Furthermore, biochemical markers and muscle biopsies will be investigated trying to link biological mechanisms to training effects.METHODS: At the Departments of Oncology at Herlev and Aarhus University Hospitals, patients with stage III/IV squamous cell carcinoma of the head and neck, scheduled for CCRT are randomized 1:1 to either a 12-week PRT program or control group, both with 1 year follow-up. Planned enrollment is 72 patients, and stratification variables are study site, sex, p16-status, and body mass index. Primary endpoint is difference in change in lean body mass (LBM) after 12 weeks of PRT, assessed by dual-energy X-ray absorptiometry (DXA). The hypothesis is that 12 weeks of PRT can attenuate the loss of LBM by at least 25%. Secondary endpoints include training adherence, changes in body composition, muscle strength, functional performance, weight, adverse events, dietary intake, self-reported physical activity, quality of life, labor market affiliation, blood biochemistry, plasma cytokine concentrations, NK-cell frequency in blood, sarcomeric protein content in muscles, as well as muscle fiber type and fiber size in muscle biopsies. Muscle biopsies are optional.DISCUSSION: This randomized study investigates the impact of a 12-week progressive resistance training program on lean body mass and several other physiological endpoints, as well as impact on adverse events and quality of life. Furthermore, a translational approach is integrated with extensive biological sampling and exploration into cytokines and mechanisms involved. The current paper discusses decisions and methods behind exercise in head and neck cancer patients undergoing concomitant chemoradiotherapy.TRIAL REGISTRATION: Approved by the Regional Ethics Committee for the Capital Region of Denmark (protocol id: H-15003725) and registered retrospectively at ClinicalTrials.gov ( NCT02557529 ) September 11th 2015.

AB - BACKGROUND: Head and neck cancer patients undergoing concomitant chemoradiotherapy (CCRT) frequently experience loss of muscle mass and reduced functional performance. Positive effects of exercise training are reported for many cancer types but biological mechanisms need further elucidation. This randomized study investigates whether progressive resistance training (PRT) may attenuate loss of muscle mass and functional performance. Furthermore, biochemical markers and muscle biopsies will be investigated trying to link biological mechanisms to training effects.METHODS: At the Departments of Oncology at Herlev and Aarhus University Hospitals, patients with stage III/IV squamous cell carcinoma of the head and neck, scheduled for CCRT are randomized 1:1 to either a 12-week PRT program or control group, both with 1 year follow-up. Planned enrollment is 72 patients, and stratification variables are study site, sex, p16-status, and body mass index. Primary endpoint is difference in change in lean body mass (LBM) after 12 weeks of PRT, assessed by dual-energy X-ray absorptiometry (DXA). The hypothesis is that 12 weeks of PRT can attenuate the loss of LBM by at least 25%. Secondary endpoints include training adherence, changes in body composition, muscle strength, functional performance, weight, adverse events, dietary intake, self-reported physical activity, quality of life, labor market affiliation, blood biochemistry, plasma cytokine concentrations, NK-cell frequency in blood, sarcomeric protein content in muscles, as well as muscle fiber type and fiber size in muscle biopsies. Muscle biopsies are optional.DISCUSSION: This randomized study investigates the impact of a 12-week progressive resistance training program on lean body mass and several other physiological endpoints, as well as impact on adverse events and quality of life. Furthermore, a translational approach is integrated with extensive biological sampling and exploration into cytokines and mechanisms involved. The current paper discusses decisions and methods behind exercise in head and neck cancer patients undergoing concomitant chemoradiotherapy.TRIAL REGISTRATION: Approved by the Regional Ethics Committee for the Capital Region of Denmark (protocol id: H-15003725) and registered retrospectively at ClinicalTrials.gov ( NCT02557529 ) September 11th 2015.

KW - Aged

KW - Body Composition/physiology

KW - Body Mass Index

KW - Carcinoma, Squamous Cell/diagnostic imaging

KW - Chemoradiotherapy/adverse effects

KW - Denmark

KW - Exercise

KW - Female

KW - Head and Neck Neoplasms/diagnostic imaging

KW - Humans

KW - Male

KW - Middle Aged

KW - Muscle Strength/drug effects

KW - Quality of Life

KW - Resistance Training

U2 - 10.1186/s12885-017-3388-0

DO - 10.1186/s12885-017-3388-0

M3 - Journal article

C2 - 28578654

VL - 17

JO - B M C Cancer

JF - B M C Cancer

SN - 1471-2407

M1 - 400

ER -

ID: 194907871